Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Heart Rhythm
|
January 17, 2024
The real-world incidence of severe QT prolongation in patients taking antipsychotic drugs
Clifford TeBay, Jamie I Vandenberg
Biophysical Reviews
|
February 1, 2022
Metabolic and electrolyte abnormalities as risk factors in drug-induced long QT syndrome
Clifford TeBay, Adam P Hill, Monique J Windley
Experimental Neurology
|
May 12, 2019
Visual discrimination impairment after experimental stroke is associated with disturbances in the polarization of the astrocytic aquaporin-4 and increased accumulation of neurotoxic proteins
Sonia Sanchez-Bezanilla, Clifford TeBay, Michael Nilsson, et al.
Journal of Pharmacological and Toxicological Methods
|
June 24, 2022
High throughput measurement of hERG drug block kinetics using the CiPA dynamic protocol
Monique J Windley, Jessica Farr, Clifford TeBay, et al.
Brain, Behavior, and Immunity
|
October 9, 2016
Reconsidering the role of glial cells in chronic stress-induced dopaminergic neurons loss within the substantia nigra? Friend or foe?
Lin Kooi Ong, Zidan Zhao, Murielle Kluge, et al.
British Journal of Pharmacology
|
November 27, 2021
Pathophysiological metabolic changes associated with disease modify the proarrhythmic risk profile of drugs with potential to prolong repolarisation
Clifford TeBay, Jeffrey R McArthur, Melissa Mangala, et al.
Stroke
|
April 12, 2018
Growth Hormone Improves Cognitive Function After Experimental Stroke
Lin Kooi Ong, Wei Zhen Chow, Clifford TeBay, et al.
Frontiers in Neurology
|
April 12, 2021
Exploring How Low Oxygen Post Conditioning Improves Stroke-Induced Cognitive Impairment: A Consideration of Amyloid-Beta Loading and Other Mechanisms
Zidan Zhao, Rebecca J Hood, Lin Kooi Ong, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Heart Rhythm
|
January 17, 2024
The real-world incidence of severe QT prolongation in patients taking antipsychotic drugs
Clifford TeBay, Jamie I Vandenberg
Biophysical Reviews
|
February 1, 2022
Metabolic and electrolyte abnormalities as risk factors in drug-induced long QT syndrome
Clifford TeBay, Adam P Hill, Monique J Windley
Experimental Neurology
|
May 12, 2019
Visual discrimination impairment after experimental stroke is associated with disturbances in the polarization of the astrocytic aquaporin-4 and increased accumulation of neurotoxic proteins
Sonia Sanchez-Bezanilla, Clifford TeBay, Michael Nilsson, et al.
Journal of Pharmacological and Toxicological Methods
|
June 24, 2022
High throughput measurement of hERG drug block kinetics using the CiPA dynamic protocol
Monique J Windley, Jessica Farr, Clifford TeBay, et al.
Brain, Behavior, and Immunity
|
October 9, 2016
Reconsidering the role of glial cells in chronic stress-induced dopaminergic neurons loss within the substantia nigra? Friend or foe?
Lin Kooi Ong, Zidan Zhao, Murielle Kluge, et al.
British Journal of Pharmacology
|
November 27, 2021
Pathophysiological metabolic changes associated with disease modify the proarrhythmic risk profile of drugs with potential to prolong repolarisation
Clifford TeBay, Jeffrey R McArthur, Melissa Mangala, et al.
Stroke
|
April 12, 2018
Growth Hormone Improves Cognitive Function After Experimental Stroke
Lin Kooi Ong, Wei Zhen Chow, Clifford TeBay, et al.
Frontiers in Neurology
|
April 12, 2021
Exploring How Low Oxygen Post Conditioning Improves Stroke-Induced Cognitive Impairment: A Consideration of Amyloid-Beta Loading and Other Mechanisms
Zidan Zhao, Rebecca J Hood, Lin Kooi Ong, et al.
Page
of 1